Before revision:  The best performing network, IVIM-NET_{optim} was compared to least squares (LS) and a Bayesian approach at different SNRs. IVIM-NET_{optim}'s performance was evaluated in 23 pancreatic ductal adenocarcinoma (PDAC ) patients.
After revision:  The best performing network, IVIM-NET_{optim} was compared to least squares (LS) and a Bayesian approach at different SNRs. IVIM-NET_{optim}'s performance was evaluated in 23 PDAC patients.